Naofumi Yui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Naofumi Yui has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Sei Sasaki
Department of Nephrology, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan
2 shared publicationsShinichi Uchida
Department of Nephrology, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan
2 shared publications- Abby Terlouw
Program in Membrane Biology and Nephrology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA
1 shared publication - Dennis Brown
Massachusetts General Hospital and Harvard Medical School
1 shared publication Fumiaki Ando
Department of Nephrology, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan
1 shared publication- Pui W. Cheung
Division of Nephrology, Program in Membrane Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
1 shared publication
Latest Publications
- Open Access
Chlorpromazine Induces Basolateral Aquaporin-2 Accumulation via F-Actin Depolymerization and Blockade of Endocytosis in Renal Epithelial Cells
We previously showed that in polarized Madin–Darby canine kidney (MDCK) cells, aquaporin-2 (AQP2) is continuously targeted to the basolateral plasma membrane from which it is rapidly retrieved by clathrin-mediated endocytosis. It then undertakes microtubule-dependent transcytosis toward the apical plasma membrane. In this study, we found that treatment with chlorpromazine (CPZ, an inhibitor of clathrin-mediated endocytosis) results in AQP2 accumulation in the basolateral, but not the apical plasma membrane of epithelial cells. In MDCK cells, both AQP2 and clathrin were concentrated in the basolateral plasma membrane after CPZ treatment (100 µM for 15 min), and endocytosis was reduced. Then, using rhodamine phalloidin staining, we found that basolateral, but not apical, F-actin was selectively reduced by CPZ treatment. After incubation of rat kidney slices in situ with CPZ (200 µM for 15 min), basolateral AQP2 and clathrin were increased in principal cells, which simultaneously showed a significant decrease of basolateral compared to apical F-actin staining. These results indicate that clathrin-dependent transcytosis of AQP2 is an essential part of its trafficking pathway in renal epithelial cells and that this process can be inhibited by selectively depolymerizing the basolateral actin pool using CPZ.
Open AccessChlorpromazine Induces Basolateral Aquaporin-2 Accumulation via F-Actin Depolymerization and Blockade of Endocytosis in Renal Epithelial Cells
We previously showed that in polarized Madin–Darby canine kidney (MDCK) cells, aquaporin-2 (AQP2) is continuously targeted to the basolateral plasma membrane from which it is rapidly retrieved by clathrin-mediated endocytosis. It then undertakes microtubule-dependent transcytosis toward the apical plasma membrane. In this study, we found that treatment with chlorpromazine (CPZ, an inhibitor of clathrin-mediated endocytosis) results in AQP2 accumulation in the basolateral, but not the apical plasma membrane of epithelial cells. In MDCK cells, both AQP2 and clathrin were concentrated in the basolateral plasma membrane after CPZ treatment (100 µM for 15 min), and endocytosis was reduced. Then, using rhodamine phalloidin staining, we found that basolateral, but not apical, F-actin was selectively reduced by CPZ treatment. After incubation of rat kidney slices in situ with CPZ (200 µM for 15 min), basolateral AQP2 and clathrin were increased in principal cells, which simultaneously showed a significant decrease of basolateral compared to apical F-actin staining. These results indicate that clathrin-dependent transcytosis of AQP2 is an essential part of its trafficking pathway in renal epithelial cells and that this process can be inhibited by selectively depolymerizing the basolateral actin pool using CPZ.
- 1 August 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 490 (3) , 1039-1044
Ser-261 phospho-regulation is involved in pS256 and pS269-mediated aquaporin-2 apical translocation
- 1 August 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 490 (3) , 1039-1044
Ser-261 phospho-regulation is involved in pS256 and pS269-mediated aquaporin-2 apical translocation
- 1 January 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 482 (4) , 524-529
Aquaporin-2 Ser-261 phosphorylation is regulated in combination with Ser-256 and Ser-269 phosphorylation
- 1 January 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 482 (4) , 524-529
Aquaporin-2 Ser-261 phosphorylation is regulated in combination with Ser-256 and Ser-269 phosphorylation